Half-dose rivaroxaban vs antiplatelet therapy for preventing silent cerebral embolism after left atrial appendage occlusion: the HALO-SCE trial
1. 系统已在2026-09-16 10:26:06对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1093/eurheartj/ehag734
文献链接: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag734/8772961
其他信息:
出版社: Oxford University Press (OUP)
作者: Kexin Wang; Linsheng Shi; Zhongbao Ruan; Hongwu Chen; Hailei Liu; Zidun Wang; Xiaohong Jiang; Mingfang Li; Minglong Chen; Weizhu Ju
全文下载地址: https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehag734/70834056/ehag734.pdf

